
Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
Research To Practice | Oncology Videos
00:00
CD3×CD19 bispecifics: cevostamab emerging
Dr Matthew Lunning introduces cevostamab (AZD0486) and the SoundTrack‑1 trial exploring CD19 bispecifics in frontline FL.
Play episode from 15:38
Transcript


